[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of US Personalized Medicine Market size

Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering

(NASDAQ:CMPX), BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced the pricing of an underwritten public offering of 33,290,000 shares of its common stock at a price to the public of $3.00 per share and

Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering

Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering GlobeNewswire August 13, 2025 BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced the pricing of an underwritten public offering of 33,290,000 shares of its

Shoucheng Joins World Humanoid Robot Games – 88 Spectators Invited

The highly anticipated World Humanoid Robot Games will officially open on 14 August at the Beijing National Speed Skating Oval and run through 17 August. This four-day technological extravaganza will serve as a premier showcase for the world's most advanced humanoid robot technologies. As the world's first large-scale comprehensive competition featuring humanoid robots as the

NVO ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Novo Nordisk A/S – September 30, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / August 12, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form-3?prid=161163&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Neogen Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – NEOG

(NASDAQ:NEOG), NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neogen Corporation (NASDAQ: NEOG) between January 5, 2023 and June 3, 2025, inclusive (the “Class Period”), of the important September 16, 2025 lead plaintiff deadline. SO WHAT: If you purchased

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Neogen Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – NEOG

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Neogen Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – NEOG GlobeNewswire August 13, 2025 NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neogen Corporation (NASDAQ: NEOG) between January 5,

Levi & Korsinsky Urges Lineage, Inc. (LINE) Shareholders to Act Before Lead Plaintiff Deadline September 30, 2025

NEW YORK CITY, NY / ACCESS Newswire / August 12, 2025 / If you suffered a loss on your Lineage, Inc. (NASDAQ:LINE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lineage-inc-lawsuit-submission-form?prid=161162&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action – NVO

NEW YORK CITY, NY / ACCESS Newswire / August 12, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Novo Nordisk A/S (NYSE:NVO) between May 7, 2025 and July 28, 2025, both dates inclusive (the "Class Period").

Scroll to Top